1. Home
  2. KNDI vs RVPH Comparison

KNDI vs RVPH Comparison

Compare KNDI & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNDI
  • RVPH
  • Stock Information
  • Founded
  • KNDI 2002
  • RVPH 2006
  • Country
  • KNDI China
  • RVPH United States
  • Employees
  • KNDI N/A
  • RVPH N/A
  • Industry
  • KNDI Auto Manufacturing
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • KNDI Consumer Discretionary
  • RVPH Health Care
  • Exchange
  • KNDI Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • KNDI 91.2M
  • RVPH 88.0M
  • IPO Year
  • KNDI N/A
  • RVPH N/A
  • Fundamental
  • Price
  • KNDI $1.21
  • RVPH $1.80
  • Analyst Decision
  • KNDI
  • RVPH Strong Buy
  • Analyst Count
  • KNDI 0
  • RVPH 5
  • Target Price
  • KNDI N/A
  • RVPH $11.40
  • AVG Volume (30 Days)
  • KNDI 113.0K
  • RVPH 1.6M
  • Earning Date
  • KNDI 03-13-2025
  • RVPH 11-14-2024
  • Dividend Yield
  • KNDI N/A
  • RVPH N/A
  • EPS Growth
  • KNDI N/A
  • RVPH N/A
  • EPS
  • KNDI N/A
  • RVPH N/A
  • Revenue
  • KNDI $118,127,232.00
  • RVPH N/A
  • Revenue This Year
  • KNDI N/A
  • RVPH N/A
  • Revenue Next Year
  • KNDI N/A
  • RVPH N/A
  • P/E Ratio
  • KNDI N/A
  • RVPH N/A
  • Revenue Growth
  • KNDI N/A
  • RVPH N/A
  • 52 Week Low
  • KNDI $0.89
  • RVPH $0.60
  • 52 Week High
  • KNDI $2.98
  • RVPH $4.50
  • Technical
  • Relative Strength Index (RSI)
  • KNDI 60.15
  • RVPH 45.36
  • Support Level
  • KNDI $1.06
  • RVPH $1.97
  • Resistance Level
  • KNDI $1.12
  • RVPH $2.14
  • Average True Range (ATR)
  • KNDI 0.06
  • RVPH 0.16
  • MACD
  • KNDI 0.01
  • RVPH -0.02
  • Stochastic Oscillator
  • KNDI 90.00
  • RVPH 29.29

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in the development, production, and distribution of electric vehicle (EV) products, EV parts, and off-road vehicle products in the Chinese market. Other product offerings include all-terrain vehicles, go-karts, utility vehicles, battery packs, and other systems. It generates maximum revenue through off-road vehicles. The company generates the majority of its revenue from the United states along with other Countries, followed by China.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: